Does Interneural Local Anesthetic Spread at the Site of Sciatic Nerve Bifurcation Shorten Block Onset Time?
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Following foot and ankle surgery, ultrasound-guided sciatic nerve block (SNB) at the popliteal fossa decreases post-operative pain and opioid consumption. At the popliteal fossa, the sciatic nerve bifurcates to form the Common Peroneal Nerve (CPN) and Tibial Nerve (TN). Studies have shown that when both branches are blocked separately distal to the bifurcation site, block onset time is reduced by 30%. Through clinical observation, the investigators found that onset time is further shortened when ultrasound-guided SNB is performed at the site of bifurcation. This is because the local anesthetic spreads interneurally. The purpose of this study is to compare the block onset time of an ultrasound-guided sciatic nerve block at the site of nerve bifurcation with the blockade of each terminal nerve separately (TN and CPN) distal to sciatic nerve bifurcation.
| Condition | Intervention | Phase |
|---|---|---|
|
Post Operative Analgesia Regional Anesthesia Sciatic Nerve Block |
Procedure: Distal Procedure: Interneural |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) |
| Official Title: | Does Interneural Local Anesthetic Spread at the Site of Sciatic Nerve Bifurcation Shorten Block Onset Time? |
- Block onset Time [ Time Frame: every 5 minutes up to 45 minutes of the block or until surgery starts ] [ Designated as safety issue: No ]We aim to compare the block onset time of an ultrasound-guided sciatic nerve block at the site of nerve bifurcation resulting in interneural spread of local anesthetic with that of blockade of each terminal nerve separately (TN and CPN), distal to sciatic nerve bifurcation. We hypothesize that sciatic nerve blockade at the site of bifurcation with interneural local anesthetic spread within a common epineural sheath results in shorter onset time compared to blockade of each terminal nerve distal to sciatic nerve bifurcation.
- Extent of longitudinal local anesthetic solution spread [ Time Frame: starting at block administration till 5 minutes after complete injection ] [ Designated as safety issue: No ]
- Nerve diameter prior to and following injection [ Time Frame: starting at block administration till 5 minutes after complete injection ] [ Designated as safety issue: No ]
- Block procedure time [ Time Frame: starting at block administration till complete injection(up to 10 minutes) ] [ Designated as safety issue: No ]
- Number of skin punctures required. [ Time Frame: starting at first attempt of block administration till complete injection(up to 10 minutes) ] [ Designated as safety issue: No ]
- Block success rate [ Time Frame: starting after complete injection up to 45 minutes ] [ Designated as safety issue: No ]
- Incidence of block-related complications [ Time Frame: immediately , at 24 hours and Post operative day 7 ] [ Designated as safety issue: Yes ]Incidence of block-related complications (vascular puncture, hematoma formation, intravascular injection and post-operative neurologic deficit) will be documented, but due to the very low incidence in all block-related complications, this study is not powered to show a difference in safety
- Postoperative pain [ Time Frame: starting at patient's arrival at post-anesthetic care unit till 120 minutes ] [ Designated as safety issue: No ]Postoperative pain: Postoperative pain using a verbal rating score (0-10, where 0= no pain, 10=excruciating pain) at 0, 30, 60, 90 and 120 min upon admission to post-anesthetic care unit.
| Estimated Enrollment: | 88 |
| Study Start Date: | July 2011 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | July 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Distal
Blockade of both terminal branches of Sciatic nerve separately, distal to bifurcation
|
Procedure: Distal
Blockade of both terminal branches of Sciatic nerve separately, distal to bifurcation
|
|
Active Comparator: Interneural
sciatic nerve blockade at the site of bifurcation
|
Procedure: Interneural
Sciatic nerve blockade at the site of bifurcation
|
Eligibility| Ages Eligible for Study: | 18 Years to 85 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- ASA physical status I-III
- 18-85 years of age, inclusive
- 50-120 kg, inclusive
- 150 cm of height or greater
Exclusion Criteria:
- Contraindications to sciatic nerve block (e.g., allergy to local anesthetics, coagulopathy, malignancy or infection in the popliteal area)
- Significant peripheral neuropathy or neurological disorder affecting the lower extremity
- Pregnancy
- History of alcohol or drug dependency/abuse
- History of significant psychiatric conditions that may affect patient assessment
Contacts and Locations| Contact: Kris Abbas, M.D | (416) 603-5800 ext 6237 | KRIS.ABBAS@UHN.CA |
| Canada, Ontario | |
| Toronto Western Hospital | Recruiting |
| Toronto, Ontario, Canada, M5T 2S8 | |
| Principal Investigator: | Anahi Perlas, MD, FRCPC | University of Toronto |
More Information
No publications provided
| Responsible Party: | University Health Network, Toronto |
| ClinicalTrials.gov Identifier: | NCT01568476 History of Changes |
| Other Study ID Numbers: | 11-0059-A |
| Study First Received: | March 6, 2012 |
| Last Updated: | March 29, 2012 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by University Health Network, Toronto:
|
Regional anesthesia Sciatic nerve block foot surgery ankle surgery Interneural local anesthetic |
Additional relevant MeSH terms:
|
Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions |
Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on June 18, 2013